These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8089864)

  • 21. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene.
    Fujiwara T; Grimm EA; Mukhopadhyay T; Zhang WW; Owen-Schaub LB; Roth JA
    Cancer Res; 1994 May; 54(9):2287-91. PubMed ID: 8162565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
    Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
    Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
    Kanai R; Eguchi K; Takahashi M; Goldman S; Okano H; Kawase T; Yazaki T
    J Gene Med; 2006 Nov; 8(11):1329-40. PubMed ID: 16955534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 tumor suppressor gene therapy for cancer.
    Roth JA; Swisher SG; Meyn RE
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):148-54. PubMed ID: 10550840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53.
    Qazilbash MH; Xiao X; Seth P; Cowan KH; Walsh CE
    Gene Ther; 1997 Jul; 4(7):675-82. PubMed ID: 9282168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer.
    Wills KN; Maneval DC; Menzel P; Harris MP; Sutjipto S; Vaillancourt MT; Huang WM; Johnson DE; Anderson SC; Wen SF
    Hum Gene Ther; 1994 Sep; 5(9):1079-88. PubMed ID: 7833367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.
    Swisher SG; Roth JA; Nemunaitis J; Lawrence DD; Kemp BL; Carrasco CH; Connors DG; El-Naggar AK; Fossella F; Glisson BS; Hong WK; Khuri FR; Kurie JM; Lee JJ; Lee JS; Mack M; Merritt JA; Nguyen DM; Nesbitt JC; Perez-Soler R; Pisters KM; Putnam JB; Richli WR; Savin M; Schrump DS; Shin DM; Shulkin A; Walsh GL; Wait J; Weill D; Waugh MK
    J Natl Cancer Inst; 1999 May; 91(9):763-71. PubMed ID: 10328106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in p53 cDNA sequence introduced by retroviral vector.
    Su S; Watanabe A; Yamamoto M; Nakajima E; Miyake K; Shimada T
    Biochem Biophys Res Commun; 2006 Feb; 340(2):567-72. PubMed ID: 16380088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent.
    Ogawa N; Fujiwara T; Kagawa S; Nishizaki M; Morimoto Y; Tanida T; Hizuta A; Yasuda T; Roth JA; Tanaka N
    Int J Cancer; 1997 Nov; 73(3):367-70. PubMed ID: 9359484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53.
    Odin L; Favrot M; Poujol D; Michot JP; Moingeon P; Tartaglia J; Puisieux I
    Cancer Gene Ther; 2001 Feb; 8(2):87-98. PubMed ID: 11263530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gene therapy with tumor suppressor gene p53 and(or) p16 on the nude mice models of NSCLC in vivo].
    Wu W; Zhang X; Qi X
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):403-5. PubMed ID: 11778504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells.
    Tango Y; Fujiwara T; Itoshima T; Takata Y; Katsuda K; Uno F; Ohtani S; Tani T; Roth JA; Tanaka N
    Hum Gene Ther; 2002 Jul; 13(11):1373-82. PubMed ID: 12162819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein.
    Cajot JF; Anderson MJ; Lehman TA; Shapiro H; Briggs AA; Stanbridge EJ
    Cancer Res; 1992 Dec; 52(24):6956-60. PubMed ID: 1458487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.
    Bleau AM; Freire J; Pajares MJ; Zudaire I; Anton I; Nistal-Villán E; Redrado M; Zandueta CN; Garmendia I; Ajona D; Blanco D; Pio R; Lecanda F; Calvo A; Montuenga LM
    Int J Cancer; 2014 Dec; 135(11):2516-27. PubMed ID: 24473991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancer.
    Muhammad T; Sakhawat A; Khan AA; Huang H; Khan HR; Huang Y; Wang J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):861-874. PubMed ID: 32088783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2.
    Bougeret C; Virone-Oddos A; Adeline E; Lacroix F; Lefranc C; Ferrero L; Huet T
    Cancer Gene Ther; 2000 May; 7(5):789-98. PubMed ID: 10830726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo gene therapy of human lung cancer using wild-type p53 delivered by retrovirus.
    Carbone DP; Minna JD
    J Natl Cancer Inst; 1994 Oct; 86(19):1437-8. PubMed ID: 8089857
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.
    Gu J; Zhang L; Swisher SG; Liu J; Roth JA; Fang B
    Oncogene; 2004 Feb; 23(6):1300-7. PubMed ID: 14676844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
    Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
    Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
    Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.